European biologic training course for type 2 inflammation by EUFOREA in 2024: key facts and lessons learned.
Saved in:
| Title: | European biologic training course for type 2 inflammation by EUFOREA in 2024: key facts and lessons learned. |
|---|---|
| Authors: | Conti DM; Allergy and Clinical Immunology Research Unit, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.; Escuela de Doctorado UAM, Centro de Estudios de Posgrado, Universidad Autónoma de Madrid, Calle Francisco Tomás y Valiente, Madrid, Spain.; The European Forum for Research and Education in Allergy and Airway Diseases Scientific Expert Team Members, Brussels, Belgium., Backer V; Department of Otorhinolaryngology, Head & Neck Surgery, and Audiology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark., Fokkens W; Department of Otorhinolarynogology and Head/Neck Surgery, Amsterdam University Medical Centres, Location AMC, University of Amsterdam, Amsterdam, Netherlands., Gevaert P; Upper Airways Research Laboratory, Department of Head and Skin, Ghent University, Ghent, Belgium., Peters A; Department of Medicine, Division of Allergy and Immunology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States., Scadding GK; Department of Allergy & Rhinology, Royal National ENT Hospital, London, United Kingdom.; Division of Immunity and Infection, University College, London, United Kingdom., Pavord I; Respiratory Medicine, NIHR Oxford Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Lau S; Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany., Wechsler M; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, United States.; Division of Biostatistics and Bioinformatics, National Jewish Health, Denver, CO, United States., Bertels X; The European Forum for Research and Education in Allergy and Airway Diseases Scientific Expert Team Members, Brussels, Belgium.; Department of Epidemiology, Erasmus MC, Rotterdam, Netherlands., Liva G; Department of Otorhinolaryngology, University of Crete, School of Medicine, Heraklion, Greece., Doulaptsi M; Department of Otorhinolaryngology, University of Crete, School of Medicine, Heraklion, Greece., Prokopakis E; Department of Otorhinolaryngology, University of Crete, School of Medicine, Heraklion, Greece., Hellings PW; Department of Otorhinolarynogology and Head/Neck Surgery, Amsterdam University Medical Centres, Location AMC, University of Amsterdam, Amsterdam, Netherlands.; KU Leuven Department of Microbiology and Immunology, Allergy and Clinical Immunology Research Unit, Leuven, Belgium.; Clinical Department of Otorhinolaryngology, Head and Neck Surgery, University Hospitals Leuven, Leuven, Belgium. |
| Source: | Frontiers in allergy [Front Allergy] 2024 Dec 12; Vol. 5, pp. 1517122. Date of Electronic Publication: 2024 Dec 12 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 9918227355906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2673-6101 (Electronic) Linking ISSN: 26736101 NLM ISO Abbreviation: Front Allergy Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2673-6101 |
|---|---|
| DOI: | 10.3389/falgy.2024.1517122 |
